European Immunohematology Market size is poised to cross USD 850 million by 2028, according to a latest forecast report by Graphical Research.
The increasing number of hematology malignancies in European countries is driving the industry growth. Disorders like thalassemia, sickle cell, and leukemia are majorly contributing to the demand for immunohematology analyzers.
Over the past few years, the number of Thalassemia patients has grown substantially, fueling product adoption. Governments of countries such as the U.K. mandatorily offer a blood test for pregnant women to determine if they carry a gene for thalassemia and other hemoglobin disorders.
Immunohematology analyzer sales are driven by technological advancements in the sector. The adoption of automated and semi-automated immunohematology systems is growing, as they are used for several applications like antibody screening, grouping, cross-matching, identification, and phenotyping.
Europe immunohematology market share from the reagents segment was more than 65% revenue share in 2021, attributed to the increasing number of hematological disorders. The upsurge in the need for regular blood testing and other disease-related blood work is fueling significant growth in the sector. Reagents are the preferred product by diagnostic centers due to their high specificity.
Browse detailed statistical insights from the report, “Europe Immunohematology Market Forecast 2028 By Product (Analyzers, Reagents), By Technology (Biochips, Gel Cards, Microplates, PCR, Erythrocyte-magnetized Technology), By End-use (Hospitals, Diagnostic Laboratories, Blood Banks), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia, Poland, Czech Republic, Hungary, Switzerland, Denmark, Ireland, Netherlands, Bulgaria, Sweden, Austria), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The Europe immunohematology market share from the blood banks segment will exceed USD 150 million by 2028, ss the number of blood transfusions increases, there is a high scope for the sales of hematology devices at blood banks. The end-user segment is expected to witness substantial development owing to the rising number of blood donors recruited during awareness programs.
The European Blood Alliance has received a grant of nearly USD 1 million through the EU4Health program to improve plasma collection in Europe. As plasma is an important raw material to create drugs for immune disorders and coagulation disorders, the agency wants to focus on strengthening the supply. The project is being fulfilled by working with blood banks of the region to increase awareness and strengthen plasma supply. Increasing fund volumes will support the blood banks sector and influence the market outlook.
The European immunohematology market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
Europe Market, By Product
Europe Market, By Technology
- Polymerase chain reaction (PCR)
- Erythrocyte-magnetized technology
Europe Market, By Application
- Diagnostic laboratories
- Blood banks
The above information has been provided for the following countries:
- Czech Republic